Organigram (OGI) Expected to Announce Earnings on Monday

Organigram (NASDAQ:OGI - Get Free Report) is expected to be releasing its Q2 2025 earnings data before the market opens on Monday, May 12th. Analysts expect Organigram to post earnings of ($0.03) per share and revenue of $61.27 million for the quarter.

Organigram (NASDAQ:OGI - Get Free Report) last issued its earnings results on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. On average, analysts expect Organigram to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Organigram Price Performance

NASDAQ:OGI traded up $0.02 during mid-day trading on Wednesday, reaching $1.12. The stock had a trading volume of 152,499 shares, compared to its average volume of 692,079. The stock has a 50-day simple moving average of $1.05 and a two-hundred day simple moving average of $1.38. Organigram has a 12 month low of $0.85 and a 12 month high of $2.11. The stock has a market capitalization of $140.80 million, a PE ratio of -2.93 and a beta of 1.35.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.